Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 01-2000 | 10-1999 | 07-1999 | 04-1999 | 01-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 280 | 220 | 220 | 260 | 220 |
| Receivables | 880 | 1,100 | 790 | 1,290 | 710 |
| Inventories | 710 | 770 | 710 | 420 | 560 |
| Other current assets | 500 | 410 | 390 | 210 | 160 |
| TOTAL | $2,370 | $2,500 | $2,110 | $2,180 | $1,650 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,150 | 1,090 | 1,087 | 1,080 | 1,070 |
| TOTAL | $1,150 | $1,090 | $1,087 | $1,080 | $1,070 |
| Total Assets | $4,560 | $4,570 | $4,010 | $4,080 | $3,550 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 500 | 680 | 590 | 420 | 540 |
| Accrued Expenses | 10 | 10 | 40 | 3 | 5 |
| TOTAL | $940 | $1,260 | $1,080 | $1,080 | $1,100 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 100 | 0 | 0 | 0 | 0 |
| TOTAL | $100 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,040 | $1,260 | $1,080 | $1,080 | $1,100 |
| Shareholders' Equity | |||||
| Common Shares | 7,430 | 6,880 | 6,660 | 6,500 | 6,150 |
| Retained earnings | -4,020 | -3,680 | -3,840 | -3,610 | -3,800 |
| Other shareholders' equity | 0 | 100 | 110 | 100 | 100 |
| TOTAL | $3,510 | $3,300 | $2,930 | $2,990 | $2,450 |
| Total Liabilities And Equity | $4,550 | $4,560 | $4,010 | $4,070 | $3,550 |